Theresa Gaffney, the lead Morning Rounds writer at STAT, has reported on a fascinating new study that reveals a significant increase in weight loss drug prescriptions among children and teens following updated guidelines from the American Academy of Pediatrics (AAP) in 2023. The study, which will be published in the AAP journal Pediatrics Open Science, analyzed electronic health records of over 310,000 patients aged 8 to 17.
According to the study, there was a 65% immediate surge in prescriptions for medications like GLP-1s after the AAP issued its revised guidelines. Furthermore, the data showed a consistent monthly increase of 5% in medication prescriptions, while rates for nutrition counseling saw minimal growth. This trend highlights a shift in pediatric obesity treatment towards pharmacological interventions rather than traditional counseling.
The study’s findings raise important questions about the impact of medical guidelines on clinical practice and the potential consequences of increased medication use among young patients. It also underscores the need for further research and discussion on the best approach to managing childhood obesity and promoting healthy lifestyles.
For more in-depth analysis and access to exclusive content like this, consider subscribing to STAT+. With a subscription, you can unlock premium articles, newsletters, events, and news alerts to stay informed on the latest developments in health care and medical research. Subscribe now to continue reading this story and explore the wealth of resources available through STAT+.
Stay tuned for more updates on health care, new research, and public policy from Theresa Gaffney and the Morning Rounds team at STAT. Sign up for the free Morning Rounds newsletter to get your daily dose of health and medicine delivered straight to your inbox every weekday.
